
Every year, millions of Muslim pilgrims from around the world gather in Mecca, Saudi Arabia, to perform the Hajj or Umrah. This massive religious congregation, characterized by extreme crowding, significantly increases the risk of infectious disease transmission. To protect both your own health and that of others, vaccination with the ACWY-type quadrivalent meningococcal conjugate vaccine (MenACWY) is a mandatory entry visa requirement imposed by the Saudi Arabian government, and an essential preparation for every pilgrim before departure.
The MenACWY vaccine is a conjugate vaccine that provides protection against four serogroups of meningococcal bacteria: A, C, W-135, and Y. These four serogroups are the most common causes of invasive meningococcal disease, including meningitis and septicemia. They are particularly prone to transmission and outbreaks in large gathering events like the Hajj.
In simple terms, "Men" stands for Meningococcus, and "ACWY" represents the four serogroups covered by the vaccine. A single dose of the MenACWY vaccine offers protection against these four high-risk strains.
Meningococcal infection is a severe bacterial illness that can lead to meningitis (inflammation of the lining around the brain and spinal cord) and septicemia (blood poisoning). The disease can progress rapidly and can be fatal. During the Hajj, millions of people are in close contact, living and praying together, creating an ideal environment for the spread of meningococcal bacteria. This has led to serious outbreaks during pilgrimages in the past.
To prevent such outbreaks, the Saudi Ministry of Health mandates that all pilgrims aged one year and above, as well as seasonal workers in the Hajj zones, must present a valid certificate of vaccination against ACWY-type meningococcal disease. This requirement protects not only you as an individual but also safeguards the health of every member of the pilgrimage community. Cases of W-type meningococcal infection in pilgrims were reported in early 2025, highlighting the critical importance of timely vaccination.
To ensure your vaccination record complies with Saudi Arabian regulations, please pay close attention to the following:
You must receive your vaccination at least 10 days before your departure. This is because your body needs sufficient time to develop an adequate immune response and protective antibodies. It is strongly recommended that you schedule an appointment at a travel health clinic 2 to 4 weeks before your trip to allow ample time.
Our centre offers the following Hong Kong Department of Health-approved ACWY quadrivalent meningococcal conjugate vaccines for pilgrims preparing for their journey:
| Vaccine Brand | Manufacturer | Remarks |
|---|---|---|
| MenQuadfi | Sanofi | Conjugate vaccine, suitable for individuals aged 12 months and above |
| Nimenrix | Pfizer | Conjugate vaccine, suitable for individuals aged 6 weeks and above |
✅ Comprehensive Vaccine Options: We offer MenACWY vaccine to meet different protection needs.
✅ Professional Consultation Services: Our healthcare team holds ISTM (International Society of Travel Medicine) accredited qualifications. We provide one-stop pre-departure health check services, including meningococcal vaccination, antibody testing, and tuberculosis (TB) screening, with personalised advice based on your travel plans and health status.
✅ Convenient Booking System: We offer transparent pricing and an online appointment system for your convenience.
We encourage timely vaccination to ensure your protection and compliance with Saudi entry requirements for your journey. Our medical team is here to address any questions or concerns you may have.
📞 Enquiries: 9446 2963 (WhatsApp ONLY)
📍 Mong Kok Branch : 1/F, 562 Nathan Road, Mong Kok (Near MTR Yau Ma Tei Station Exit A2) View Map
📍 Wan Chai Branch: Room 13D, Derby Commercial Building, 113-117 Wan Chai Road, Wan Chai (Near MTR Wan Chai Station Exit A3) View Map
ACWY vaccinations for Hajj and Umrah travellers-NHS
Advice for pilgrims visiting Mecca, Saudi Arabia (Hajj and Umrah)